THIS
CONSULTING AGREEMENT (the
“Agreement”) is made and entered into as of the date
indicated below (the “Effective Date”) between
OMNIMMUNE CORP., a Texas corporation (“Omnimmune”), and
Mark Germain, a resident of the State of New York
(“Consultant”). Omnimmune and Consultant are
sometimes collectively referred to in this Agreement as the
“Parties.”
Authorized
Signature: /s/ Harris A. Lichtenstein
Printed
Name: Harris A. Lichtenstein, Ph.D.
4600 Post Oak
Place, Suite 352
Telephone No.:
(713) 622-8400
Facsimile No.:
(713) 626-7566
Authorized
Signature: /s/ Mark S.
Germain
Printed
Name: Mark Germain
|
15 Bank Street, Apt. 102-I
|
|
|
|
EFFECTIVE
DATE: March 1, 2008
ADD IT
IONAL TERMS AND COND IT IONS OF THIS AGREEMENT BEGIN ON
THE FOLLOWING PAGE.
TERMS AND COND
IT IONS
Omnimmune wishes to engage
Consultant to provide certain Services (defined below) to
Omnimmune, and Consultant wishes to provide the Services to
Omnimmune, all pursuant to the terms and conditions set forth in
this Agreement;
In consideration of the benefits
they will each receive as a result of the relationship created by
this Agreement and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the
Parties, intending to be legally bound by this Agreement, hereto
hereby agree as follows:
1. Definitions
. The following are the definitions for certain defined
terms used in this Agreement:
|
|
“Proprietary Information”
shall mean any and all proprietary
technical and nontechnical data, information, agreements, documents
or other property of Omnimmune or any affiliate thereof, other than
“Trade Secrets,” and proprietary rights thereto, which
is of tangible or intangible value to Omnimmune or any affiliate
thereof and is not public information or is not generally known or
available to Omnimmune's competitors, but is known only to
Omnimmune or its affiliates and their employees, independent
contractors or agents to whom it must be confided in order to apply
it to the uses intended, including, without limitation, all
business methods, practices and concepts; business and financial
information and records, including, without limitation, accounting
records, tax returns, financial statements, projections, forecasts
or other budgets, other financial data or plans, business plans and
strategies; product plans, customer lists and other
customer-related i nformation; vendor or supplier lists and
other vendor or supplier-related information;
computer or data base files; passwords or other access codes;
software and operating code or source code relating thereto; any
and all contractors, subcontractors; inventions and
invention-related reports, analyses, notes, interpretations,
formulae, processes, and patent applications, and the proprietary
rights thereto; the terms of this Agreement and any other agreement
between the Parties.
|
|
|
“Trade Secrets”
shall mean Proprietary Information
(including, but not limited to a business information, technical or
non-technical data, formulas, patterns compilations, programs,
devices, methods, techniques, drawings, processes, financial data,
financial plans, product plans, lists of actual or potential
customers or suppliers) that: (a) derives economic
value, actual or potential, from not being generally known to, and
not being readily ascertainable by proper means by, other persons
who can obtain economic value from its disclosure or use; and
(b) is the subject of efforts that are reasonable under the
circumstances to maintain its secrecy. To the extent
that applicable law mandates a definition of “trade
secret” inconsistent with the foregoing definition, then the
foregoing definition shall be construed in such a manner as to be
consistent with the mandated definition under applicable
law.
|
2. Services
. Consultant hereby agrees during the “Term”
(as defined in Section 5) to perform the
“Services” set forth in Schedule A to this
Agreement. Consultant agrees to perform the Services in
a diligent, timely, effective and professional
manner. Consultant agrees to provide Omnimmune with
periodic information regarding the status of and progress with
respect to the Services, as and to the extent reasonably requested
by Omnimmune as described on Schedule A .
3. Restrictive
Covenants .
|
|
Nondisclosure. Consultant
acknowledges that he may be exposed to certain Proprietary
Information and Trade Secrets and the proprietary rights thereto
during the Term, and his unauthorized use or disclosure of such
information, data or rights could cause immediate and irreparable
harm to Omnimmune. Accordingly, except to the extent
that he is required to use such information or data to perform his
obligations as a consultant of Omnimmune, Consultant
agrees that he shall not (and shall take full responsibility for
ensuring that none of his agents), without the express and duly
authorized written consent of Omnimmune, which consent may be
withheld, delayed, denied or conditioned in Omnimmune’s sole
and absolute discretion, use or modify for use, directly or
indirectly in any way for any Person, any Proprietary Information
or Trade Secrets or the proprietary rights thereto, during the term
of this Agreement and following the termination of this
Agreement. Consultant agrees that any Proprietary
Information or Trade Secrets or the proprietary rights thereto
shall remain the exclusive property of Omnimmune, and Consultant
shall not have any ownership interest therein. In addition, except
to the extent he is required to use such information or data to
perform his obligations as an independent contractor of Omnimmune,
Consultant agrees that he shall not (and shall take full
responsibility for ensuring that none of his agents), without the
express and duly authorized written consent of Omnimmune,
redistribute, market, publish, disclose or divulge to any other
Person, (i) any of Omnimmune's Proprietary Information and
proprietary rights thereto during the Term and for a period of
three (3) years immediately thereafter; and (ii) any of Omnimmune's
Trade Secrets and proprietary rights thereto at any time during
which such information shall constitute a Trade Secret (whether
before, during or after termination of this Agreement).
|
|
|
Limitation on Solicitation of Personnel. During
the Term and for a period of three (3) years immediately
thereafter, Consultant shall not, directly or indirectly, alone or
in conjunction with any other person, solicit any employee,
other personnel or independent contractor of Omnimmune (a
“Protected Person”) for the purpose of encouraging such
Protected Person to sever an employment, contractual or other
relationship with Omnimmune or (iii) hire or otherwise retain
a Protected Person to perform services of a nature substantially
similar to that which such Protected Person performed for Omnimmune
within a three (3) year period prior to any such hiring or
engagement.
|
4. Term
. Unless terminated earlier as provided below, the term
of Consultant's relationship with Omnimmune pursuant to this
Agreement (the “Term”) shall commence as of the
Effective Date and continue for an initial period of time as set
forth on Schedule B (the “Initial Term
|